Skip to main content

Global Defibrillator Market to Expand at 5.3% CAGR and Reach USD 14,806.4 Million by 2026

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, India, Dec. 15, 2020 (GLOBE NEWSWIRE) — The defibrillator market size was valued at USD 9,836.8 Million in 2018. Fortune Business Insights™ states that the market will be valued at USD 14,806.4 Million by 2026, thereby exhibiting a CAGR of 5.3% during the forecast period. North America generated revenue of USD 4,414.1 Million in 2018 and is expected to dominate the market throughout the forecast period. Growing installations of external defibrillators in hospitals, as well as public places such as schools, hotels, streets, railway stations, and others with the aim to prevent fatalities from sudden cardiac arrest, is prominently responsible to hold a higher share of the global defibrillator market in North America.Defibrillator Industry Developments:
In April 2019, the government of Australia announced the plan to install an estimated 1,000 defibrillators in parks across the country with aim to offer more safety and availability of emergency services for the people who are suffering from cardiac disorders.In June 2018, Koninklijke Philips N.V., announced the acquisition of Remote Diagnostic Technologies, an U.K. based cardiac management and data management company with aim to expand its portfolio in cardiac therapeutic business. Additionaly, Koninklijke Philips N.V is expecting to embed these new technologies in defibrillator in order to offer premium service to the customers.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/defibrillator-market-100950
FDA Approves Wearable Defibrillator for Children

 The FDA approved ‘LifeVest’ defibrillator has been successful ever since it was announced in 2017.  The LifeVest was launched as a wearable device, suitable for children at the risk of sudden cardiac arrest. The device consists of an electrode belt and a cloth that surrounds the chest of the patient using it.Additionally, the device also makes use of a monitor that is used for real time analysis. The efficacy of the device has lifted the otherwise moderately rising defibrillator market. The device provides a shock to the heart, whenever a failure is detected, allowing it to restore its heartbeat. LifeVest has a positive outcome on the global defibrillators market and is likely to enable growth of the market in the coming years.
To get to know more about the short-term & long-term impact of COVID-19 on this market, please click here: https://www.fortunebusinessinsights.com/industry-reports/defibrillator-market-100950
Boston Scientific Proposes a Defibrillator with 70% More Pacing OptionsThe size of these devices are what differentiates them from its counterparts and it has created a rising uptake within end users. The company has submitted on its website that these devices are approximately 20% smaller than the existing devices, produced by its counterparts. The approvals for Boston Scientific’s latest devices is likely to enable the growth of the global market in the forthcoming years.
Quick Buy –  Defibrillator Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100950
List of the leading companies that are operating in the global defibrillator market:Asahi Kasei CorporationPhilips HealthcareDefibtech, LLC.Cardiac ScienceStrykerCU Medical System Inc.MedtronicBoston Scientific CorporationBiotronikLivaNova PlcAbbottMicroportOther prominent players
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/defibrillator-market-100950
Global Defibrillator Market Segmentation:By Type •              Implantable Cardioverter Defibrillator (ICD)•              Transvenous ICD•              Single Chamber ICD•              Dual Chamber ICD•              CRT-D (cardiac resynchronization therapy- defibrillator)•              Subcutaneous ICD•              External Defibrillator•              Automated External Defibrillator (AED)•              Manual and Semi-Automatic External Defibrillator•              Wearable External DefibrillatorBy End User         •              Hospitals & Clinics•              Ambulatory, Schools and other Public PlacesBy Geography      •              North America (USA and Canada)•              Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)•              Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)•              Rest of the World
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/defibrillator-market-100950
SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companiesDetails in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facilityNumber of procedures and average price of proceduresReplacement rate and pricing of capital equipmentMarket dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunitiesMarket & technological trends, new product developments, product pipeline.
Have a Look at Related Reports:In-vitro Diagnostics (IVD) Market Share & Industry Analysis, By Product Type (Instruments, Reagents & Consumables), By Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Point of Care, Hematology and Others), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, Others), By End User (Clinical Laboratories, Hospitals, Physicians Offices, Others) and Regional Forecast, 2019 – 2026Hepatitis C Drug Market Share & Industry Analysis, By Product (NS5A Inhibitor (Protease Inhibitors), Fixed-dose Combination, Others), By Disease Type (Acute Hepatitis C, Chronic Hepatitis C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026Schizophrenia Drugs Market Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026Sharps Containers Market Share & Industry Analysis, By Product Type (Multipurpose Containers, Patient Room Containers, Phlebotomy Containers), By Waste Generators (Hospitals, Pharmacies, Academic & Research Institutes, Others), By Usage (Reusable Containers and Single-Use Containers), By Waste Type (Sharps Waste, Infectious Waste), By Size (1–2 Gallons, 2–4 Gallons, 4–8 Gallons Others) and Regional Forecast, 2019 – 2026Aesthetic Implants Market Share & Industry Analysis, By Product (Breast Implants, Dental Implants, Facial Implants & Others), By Gender (Female, Male), By End-user (Hospitals, Specialty Clinics), and Regional Forecast, 2019-2026
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/defibrillator-market-9176

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.